HUMAN geneticist and personalised medicinal researcher Dr Eric Hoffman of the Children’s Medical Centre in Washington D.C., will share at the World Health Care Congress Middle East how a personalised medicinal approach to common health issues can have a global impact on advancing prevention and treatment.
Dr. Hoffman will shed light on the role of technology in mapping biological processes related to the development of diseases like metabolic syndrome, a set of five precursors to diabetes, and the importance of early identification, that allows health care providers to develop and target interventions which halt the progression of these symptoms before they develop into more serious stages, for example, type 2 diabetes or advanced cardiovascular disease.
He explained, “We are entering the ‘data driven’ age of medicine, where the six billion letters of a person’s genetic code will be deciphered and interpreted while in the waiting room.
The challenge is to interpret this flood of individualised data, and realize the promise of personalized medicine. A key focus is type 2 diabetes, where genetics and environment combine in complex relationships, is creating a disease that is affecting 30 per cent of people living ‘westernized’ lifestyles.”
According to the World Health Organization, the UAE has the world’s second highest diabetes rate, with 29 per cent of the population over 30 years of age battling the disease.